When the Third Time Is Not the Charm—Trial Outcomes in Idiopathic Pulmonary Fibrosis | Pulmonary Medicine | JAMA

Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease that inevitably results in respiratory failure and death within 3 to 5 years of

Related Keywords

Evam Carmona , ,Division Of Pulmonary ,National Institutes Of Health ,Department Of Internal Medicine ,Blood Institute ,Drug Administration ,Prone Precise Asthma Network ,Boehringer Ingelheim ,Computer Aided Lung Informatics ,Pathology Evaluation ,Precision Interventions ,Asthma Network ,Internal Medicine ,Critical Care Medicine ,Mayo Clinic ,Interest Disclosures ,National Institutes ,